Date of Report (Date of earliest event reported) November 17, 2014
|
||
Amarillo Biosciences, Inc.
|
||
(Exact Name of registrant as specified in its charter)
|
||
Texas
|
0-20791
|
75-1974352
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
4134 Business Park Drive, Amarillo, Texas 79110-4225
|
||
(Address of principal executive offices) (Zip Code)
|
||
Registrant’s telephone number, including area code (806) 376-1741
|
||
(Former name or former address, if changed since last report.)
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.03.
|
Bankruptcy or Receivership
|
AMARILLO BIOSCIENCES, INC.
|
|
Date: November 17, 2014
|
By: /s/ Bernard Cohen
|
Bernard Cohen, Vice President
and Chief Financial Officer
|